[96a5a0]: / output / allTrials / identified / NCT00746694_identified.json

Download this file

153 lines (153 with data), 5.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
{
"info": {
"nct_id": "NCT00746694",
"official_title": "Epidemiological Study to Assess the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Pegylated Liposomal Doxorubicin",
"inclusion_criteria": "* Women 18 years of age or older.\n* Participants with metastatic breast or ovarian cancer who are receiving treatment with pegylated liposomal doxorubicin.\n* Participants who have given their written consent.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Participants who are currently participating in a clinical trial.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Women 18 years of age or older.",
"criterions": [
{
"exact_snippets": "Women",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "18 years of age or older",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Participants with metastatic breast or ovarian cancer who are receiving treatment with pegylated liposomal doxorubicin.",
"criterions": [
{
"exact_snippets": "metastatic breast or ovarian cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": [
"metastatic breast cancer",
"metastatic ovarian cancer"
]
}
]
},
{
"exact_snippets": "receiving treatment with pegylated liposomal doxorubicin",
"criterion": "treatment",
"requirements": [
{
"requirement_type": "current treatment",
"expected_value": "pegylated liposomal doxorubicin"
}
]
}
]
},
{
"line": "* Participants who have given their written consent.",
"criterions": [
{
"exact_snippets": "Participants who have given their written consent.",
"criterion": "written consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "healthy volunteers",
"requirements": [
{
"requirement_type": "participation",
"expected_value": true
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Participants who are currently participating in a clinical trial.",
"criterions": [
{
"exact_snippets": "Participants who are currently participating in a clinical trial",
"criterion": "current participation in a clinical trial",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}